$40M Deal OK'd For Suit Over Emergent Vax Flub

A Maryland federal judge approved a $40 million settlement between Emergent BioSolutions Inc. and a class of investors claiming that it misled them about its ability to meet the demands of...

Already a subscriber? Click here to view full article